Folio Biosciences and Conversant Bio have merged to create the life science industry’s premier provider of research services and biospecimen solutions. Folio Conversant will offer an extensive array of quality biospecimens, particularly FFPE tissue and blood, supported by comprehensive laboratory and analytic services.

Please use these websites as resources while our new website is under development.

Our Capabilities

Laboratory Services

Biosample laboratory services and data analytics performed in ISO-9001 or CLIA-certified environments.

  • •  Blood Processing   
  • •  Sample Validation   
  • •  Data Security   
  • •  Analytical Services   
  • •  Tissue Analysis   
  • •  Molecular Testing   
  • •  Flow Cytometry Analysis   

Sample Procurement

Customized biospecimen procurement through an extensive network of 100+ clinical sites and the largest commercial FFPE biobank in the U.S.

  • •  Unique Cohorts   
  • •  Clinical Data   
  • •  Quality Control   
  • •  IRB Approved   
  • •  Diverse Biobank Inventory   
    (Tissue, Blood, Biofluids, etc.)

Scientific Consulting

Custom consulting and interpretation provided by our knowledgeable and experienced scientific team.

  • •  Histology   
  • •  Pathology   
  • •  Protocol Development   
  • •  Assay Development   
  • •  Clinical Targeting   
  • •  Sample Pre-Screening   

The Vision

A unique research service company providing consulting, laboratory services, and comprehensive biosamples supporting the research and development of new treatments for life-threatening and chronic diseases.





“We will continue our investment in the recruitment and acquisition of leading talent and technology to provide our clients’ access to the broadest array of biospecimens and to significantly enhance our laboratory and scientific consulting services. Our mission is to help our clients accelerate their research and development of new diagnostics and therapies.”

  Glenn Bilawsky
CEO, Folio Conversant

About The Merger

Folio Biosciences

Established by a Nobel-prize winning scientist, Folio is the largest U.S. biobank with more than 8 million specimens, primarily FFPE tissue. The Columbus, Ohio-based company offers custom-procurement, pathology and histology services, including an in-house CLIA certified lab for sectioning and TMA manufacturing of human tissues. Over the years, Folio has earned a reputation as a high-quality science provider of biospecimens and analytical services.

“Folio was founded on the principle of providing customers with the highest quality biospecimens and clinical insights to advance their work toward finding new cures and treatments. I’m extremely pleased to be joining forces with another leader who shares this commitment.”

  Dr. Adel Mikhail
Co-Founder and CEO, Folio Biosciences

Conversant Bio

Founded in 2006, Conversant Bio is now the largest U.S. custom blood procurement company for oncology and rheumatology research. The company is headquartered in Huntsville, Alabama’s HudsonAlpha Institute for Biotechnology, a leader in genetics and genomic research. Conversant’s success has been built on a large prospective collections network of more than 70 IRB reviewed clinical sites. Through dedication to customer service, Conversant Bio supported over 1,500 research projects in 2017 alone.

“By combining Folio and Conversant’s capabilities, we will be uniquely positioned to address the highly specific needs of our customers. We will be especially adept at supporting earlier-stage research that requires particular or difficult-to-obtain specimens and insights.”

  Marshall Schreeder
Co-Founder and CEO, Conversant Bio